Schoelwer Melissa J, DeBoer Mark D, Breton Marc D
Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
Diabetologia. 2024 Oct;67(10):2075-2084. doi: 10.1007/s00125-024-06218-0. Epub 2024 Jul 12.
Children with type 1 diabetes and their caregivers face numerous challenges navigating the unpredictability of this complex disease. Although the burden of managing diabetes remains significant, new technology has eased some of the load and allowed children with type 1 diabetes to achieve tighter glycaemic management without fear of excess hypoglycaemia. Continuous glucose monitor use alone improves outcomes and is considered standard of care for paediatric type 1 diabetes management. Similarly, automated insulin delivery (AID) systems have proven to be safe and effective for children as young as 2 years of age. AID use improves not only blood glucose levels but also quality of life for children with type 1 diabetes and their caregivers and should be strongly considered for all youth with type 1 diabetes if available and affordable. Here, we review key data on the use of diabetes technology in the paediatric population and discuss management issues unique to children and adolescents.
1型糖尿病患儿及其护理人员在应对这种复杂疾病的不可预测性方面面临诸多挑战。尽管管理糖尿病的负担仍然很重，但新技术减轻了一些负担，使1型糖尿病患儿能够实现更严格的血糖管理，而不必担心低血糖过多。仅使用持续葡萄糖监测就能改善治疗效果，被认为是儿科1型糖尿病管理的标准护理方法。同样，自动胰岛素输送（AID）系统已被证明对年仅2岁的儿童是安全有效的。使用AID不仅能改善1型糖尿病患儿的血糖水平，还能提高他们及其护理人员的生活质量，如果条件允许且费用可承受，所有1型糖尿病青少年都应强烈考虑使用。在此，我们回顾了儿科人群中糖尿病技术使用的关键数据，并讨论了儿童和青少年特有的管理问题。
